1.致癌基因
1.a gene that can cause a cell to become malignant.
1.The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular origin.
癌基因与另一个基因融合的遗传翻译产物。后者可能是病毒性或细胞源性。
2.The occurrence mechanisms on cancer including mutation of oncogene and antioncogene, effect of environmental factors were reviewed.
根据近年的研究进展，从癌基因与抑癌基因的突变及环境因素的影响等方面综述了癌症的发生机理。
3.Contrast with proto-oncogene and with tumor-suppressor gene.
相对于原癌基因和肿瘤抑制基因。
4.Kras gene, one of the oncogene, is frequently mutated in tumors.
Kras基因是一种癌基因，在肿瘤中的突变率较高。
5.Moreover, transformation of tumor cells is involved in oncogene amplification or promoter enhancement.
而且，肿瘤细胞的转型通常涉及致癌基因的扩大，以及启动子的加强。
6.Some of them are oncogene protein and suppressor gene protein, while some of them are involved in apoptosis, etc.
其中有的是癌基因表达蛋白，有的是抑癌基因表达蛋白，还有的则参与凋亡过程等。
7.HRG is an activator of the HER-2 oncogene, promoting breast cancer growth and tumor formation in laboratory models.
HRG是HER-2原癌基因的激动子，在动物模型中促进乳癌细胞的生长和肿瘤的形成。
8.The KRAS proto-oncogene product lies downstream of EGFR, and the mutation frees the receptor from normal regulation in cell-growth control.
原癌基因KRAS是表皮生长因子受体下游产物，它的突变使其不受在细胞生长控制中正常调节的受体影响。
9.STUDY ON PATHOLOGY OF GASTRIC MUCOSA AND EXPRESSION OF ONCOGENE IN CAG MODEL WHICH COMBINED WITH SYNDROME AND DISEASE?
CAG证病结合模型的胃粘膜病理和癌基因表达研究？
10.Objective To introduce oncogene. Whicth is relation to the occurrence and to evaluate the connection with the Imaging diagnosis and therapy.
目的介绍与肝癌发生发展及转移有关的癌基因，并探讨他们与影像诊断和治疗的关系。